A Structured Review and Guide Through Studies on Health-Related Quality of Life in Kidney Cancer, Hepatocellular Carcinoma, and Leukemia

被引：16

作者：

Liu, Jia ^{[1
]}

Mittendorf, Thomas ^{[1
]}

von der Schulenburg, J. -Matthias ^{[1
]}

机构：

[1] Leibniz Univ Hannover, Ctr Hlth Econ, D-30167 Hannover, Germany

来源：

CANCER INVESTIGATION | 2010年 / 28卷 / 03期

关键词：

Kidney cancer; Hepatocellular carcinoma; Leukemia; Patient-reported outcome; Quality of life; Health-related quality of life; LONG-ACTING OCTREOTIDE; CHRONIC LYMPHOCYTIC-LEUKEMIA; GROWTH-HORMONE TREATMENT; CHRONIC MYELOID-LEUKEMIA; PHASE-III TRIAL; FUNCTIONAL ASSESSMENT; INTERFERON-ALPHA; EORTC QLQ-C30; DOUBLE-BLIND; THERAPY;

D O I：

10.3109/07357900903287022

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

Aim of this paper is to review and describe Health-Related Quality of Life (HRQoL) measures applied in kidney cancer, hepatocellular carcinoma, and leukemia patients under drug therapy. A comprehensive search in PubMed was conducted to identify studies assessing quality of life (OoL) in these indications. In total 32 studies, including four studies through reference list checking and 21 different HRQoL instruments, were identified. Six generic, five disease-specific, and 10 domain-specific instruments were identified. In conclusion no overall standards in HRQoL measurement could be observed in the respective indications.

引用

页码：312 / 322

页数：11

共 75 条

[1]

THE EUROPEAN-ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER QLQ-C30 - A QUALITY-OF-LIFE INSTRUMENT FOR USE IN INTERNATIONAL CLINICAL-TRIALS IN ONCOLOGY [J].

AARONSON, NK ;

AHMEDZAI, S ;

BERGMAN, B ;

BULLINGER, M ;

CULL, A ;

DUEZ, NJ ;

FILIBERTI, A ;

FLECHTNER, H ;

FLEISHMAN, SB ;

DEHAES, JCJM ;

KAASA, S ;

KLEE, M ;

OSOBA, D ;

RAZAVI, D ;

ROFE, PB ;

SCHRAUB, S ;

SNEEUW, K ;

SULLIVAN, M ;

TAKEDA, F .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (05) :365-376

[2]

[Anonymous], 2008, CANC FACTS FIG

[3]

[Anonymous], Guidance for industry: patient reported outcome measures: use in medical product development to support labelling claims

[4]

THE STRUCTURE AND PROPERTIES OF THE SENSE OF COHERENCE SCALE [J].

ANTONOVSKY, A .

SOCIAL SCIENCE & MEDICINE, 1993, 36 (06) :725-733

[5]

The functional assessment of cancer therapy-BRM (FACT-BRM): A new tool for the assessment of quality of life in patients treated with biologic response modifiers [J].

Bacik, J ;

Mazumdar, M ;

Murphy, BA ;

Fairclough, DL ;

Eremenco, S ;

Mariani, T ;

Motzer, RJ ;

Cella, D .

QUALITY OF LIFE RESEARCH, 2004, 13 (01) :137-154

[6]

Randomized controlled trial of tamoxifen in advanced hepatocellular carcinoma [J].

Barbare, JC ;

Bouché, O ;

Bonnetain, F ;

Raoul, JL ;

Rongier, P ;

Abergel, A ;

Boige, V ;

Denis, B ;

Blanchi, A ;

Pariente, A ;

Milan, C ;

Bedenne, L .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (19) :4338-4346

[7]

Long-acting octreotide versus placebo for treatment of advanced HCC:: A randomized controlled double-blind study [J].

Becker, Gerhild ;

Allgaier, Hans-Peter ;

Olschewski, Manfred ;

Zaehringer, Andreas ;

Blum, Hubert Erich .

HEPATOLOGY, 2007, 45 (01) :9-15

[8]

Development of a questionnaire module to supplement the EORTC QLQ-C30 to assess quality of life in patients with hepatocellular carcinoma, the EORTC QLQ-HCC18 [J].

Blazeby, JM ;

Currie, E ;

Zee, BCY ;

Chie, WC ;

Poon, RT ;

Garden, OJ .

EUROPEAN JOURNAL OF CANCER, 2004, 40 (16) :2439-2444

[9]

Quality of life assessment in radionuclide therapy:: a feasibility study of the EORTC QLQ-C30 questionnaire in palliative 131I-lipiodol therapy [J].

Brans, B ;

Lambert, B ;

De Beule, E ;

De Winter, F ;

Van Belle, S ;

Van Vlierberghe, H ;

de Hemptinne, B ;

Dierckx, RA .

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2002, 29 (10) :1374-1379

[10]

EuroQol: The current state of play [J].

Brooks, R .

HEALTH POLICY, 1996, 37 (01) :53-72

← 1 2 3 4 5 6 7 8 →